Thursday, 17 August 2017

FDA approves Pfizer's drug for rare blood cancer

(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it approved Pfizer Inc's treatment for a rare type of blood cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)